admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Silo Pharma Announces Collaboration with University California San Francisco to study...

The Psyence Group Announces its Formal Entry into Jamaica with the...

Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in...

Field Trip Health Ltd. Applies to List Its Common Shares on...

PT247 – Julian Vayne – Magic, Prohibition, and New Models for...

Psychedelic Bulletin: Poll Shows Support for Psilocybin in the UK; Psychedelics-tinged...

Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

PTSF62 – Senate Bill 519, Ketamine, and Psilocybin-producing Cicadas

Op-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance

Field Trip Health Ltd. to Commence Trading on the Toronto Stock...

1...212213214...218 Page 213 of 218

EDITOR PICKS

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin